Latest news
This Week at FDA: Inspection reorg, acting CBER chief eyes IND reforms, and more - RAPSRAPS · Fri, 07 Aug 2026 20:43:00 GMTMDUFA VI deal promises to boost domestic priorities, review consistency - RAPSRAPS · Thu, 06 Aug 2026 21:37:00 GMTRecon: FDA approves first drug for type 1 narcolepsy, mRNA flu vaccine; No merger talks between AstraZeneca-BMS - RAPSRAPS · Thu, 06 Aug 2026 18:15:00 GMTFDA seeks feedback on quantitative medicine network - RAPSRAPS · Tue, 04 Aug 2026 20:54:00 GMTFDA updates TDS guidances on adhesive performance, skin irritation and sensitization studies - RAPSRAPS · Mon, 03 Aug 2026 20:56:00 GMTRecon: AstraZeneca, BMS discuss merger; FDA broadens indication for Novartis’ Pluvicto - RAPSRAPS · Mon, 03 Aug 2026 16:51:00 GMTThis Week at FDA: ‘Simple reform’ reorg, adcomm updates, and more - RAPSRAPS · Fri, 31 Jul 2026 21:20:00 GMTFDA unveils FY 2027 user fee rates - RAPSRAPS · Thu, 30 Jul 2026 07:00:00 GMT